Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

Novo Nordisk wins FDA nod for Wegovy pill, prepares $149 cash-pay launch

Novo Nordisk A/S (NASDAQ:NVO) received U.S. Food and Drug Administration approval on Monday for the first oral version of its blockbuster weight-loss medication Wegovy, setting the stage for a January launch that will bypass traditional insurance hurdles

Leia mais: Novo Nordisk wins FDA nod for Wegovy pill, prepares $149 cash-pay launch